↓ Skip to main content

Cochrane Database of Systematic Reviews

Chlorpromazine versus placebo for schizophrenia

Overview of attention for article published in Cochrane database of systematic reviews, January 2014
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (95th percentile)
  • Good Attention Score compared to outputs of the same age and source (76th percentile)

Mentioned by

blogs
2 blogs
twitter
25 X users
peer_reviews
1 peer review site
weibo
1 weibo user
facebook
1 Facebook page
wikipedia
3 Wikipedia pages
video
1 YouTube creator

Citations

dimensions_citation
74 Dimensions

Readers on

mendeley
385 Mendeley
Title
Chlorpromazine versus placebo for schizophrenia
Published in
Cochrane database of systematic reviews, January 2014
DOI 10.1002/14651858.cd000284.pub3
Pubmed ID
Authors

Clive E Adams, George A Awad, John Rathbone, Ben Thornley, Karla Soares‐Weiser

Abstract

Chlorpromazine, formulated in the 1950s, remains a benchmark treatment for people with schizophrenia.

X Demographics

X Demographics

The data shown below were collected from the profiles of 25 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 385 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United Kingdom 1 <1%
Netherlands 1 <1%
Canada 1 <1%
Unknown 382 99%

Demographic breakdown

Readers by professional status Count As %
Student > Master 65 17%
Researcher 48 12%
Student > Bachelor 47 12%
Student > Ph. D. Student 40 10%
Student > Doctoral Student 26 7%
Other 64 17%
Unknown 95 25%
Readers by discipline Count As %
Medicine and Dentistry 106 28%
Psychology 63 16%
Nursing and Health Professions 32 8%
Social Sciences 21 5%
Pharmacology, Toxicology and Pharmaceutical Science 14 4%
Other 49 13%
Unknown 100 26%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 29. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 18 May 2023.
All research outputs
#1,340,990
of 25,457,858 outputs
Outputs from Cochrane database of systematic reviews
#2,844
of 11,499 outputs
Outputs of similar age
#14,482
of 319,274 outputs
Outputs of similar age from Cochrane database of systematic reviews
#52
of 224 outputs
Altmetric has tracked 25,457,858 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 94th percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 11,499 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 40.0. This one has done well, scoring higher than 77% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 319,274 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 95% of its contemporaries.
We're also able to compare this research output to 224 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 76% of its contemporaries.